TheraCell Inc., a leading allograft solution company, announced that it has been acquired by Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and...
Xylyx Bio develops physiologic disease models that enable researchers to gain insights into tumor biology and evaluate the efficacy of drug candidates. Their IN...
Cue Health Inc., the healthcare technology company behind one of the country's most accurate COVID-19 tests and BioReference Laboratories, Inc., an OPKO Health company...
Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application...
Bristol Myers Squibb announced results from the Phase 3 VALOR-HCM study, which showed the addition of mavacamten, an investigational, first-in-class cardiac myosin inhibitor, significantly...
